The goal of the Hematologic Malignancies Transdisciplinary Cancer Team is to bring expertise from different disciplines in basic and clinical research to advance our understanding of hematologic malignancies including leukemia, lymphoma and multiple myeloma and to translate that information to clinical trials to improve patient care in South Carolina.
The team consists of members with expertise in basic biology, oncology, pathology, surgery, population science, pharmacology, engineering, and informatics and biostatistics.